Cleveland Clinic Expands Psychedelic Research and Launches First Psilocybin Trial in Northeast Ohio
Psilocybin is the primary psychoactive compound in magic mushrooms and has been researched in clinical trials for the last two decades. Known as a recreational drug in the past, it is being studied in academic medical settings in combination with psychotherapy for treating addiction, depression and other mood disorders. Cleveland Clinic is now part of a … Read More